BioMed X

Kidneys
#BioMed X #Diabetes #European Union #Kidney disease

Global research launched into early diabetic kidney disease 

Pharma innovation hub BioMed X has partnered with the government of Barbados to launch global research into a therapy for early diabetic kidney disease.  The new global call for research proposals, entitled ‘AI-Enabled Therapy of Early Diabetic Kidney Disease in Barbados’, addresses the biological heterogeneity of early diabetic kidney disease in the Barbadian population. Read More

#Business & Investment #News

#BioMed X #Biomedical research #Funding #National Institutes of Health (NIH) #United States

XBridge Program launches for researchers impacted by NIH cuts

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of its XBridge Program, a fast-track initiative designed to support US-based biomedical researchers impacted by the current NIH funding gaps, hiring freezes, and grant terminations.   The programme is a kind of matchmaking… Read More

#News